Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, AdaptHealth Corp. reported revenue of $3.24B, down 0.5% year over year. Operating margin was 2.8% and net margin -2.2%, on a free-cash-flow margin of 6.8% with capital expenditure at 11.8% of revenue. Every figure is computed directly from AHCO's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $3.24B | 2.8% | -2.2% |
| FY2024 | $3.26B | 8.1% | 2.8% |
| FY2023 | $3.20B | -18.7% | -21.2% |
| FY2022 | $2.97B | 6.4% | 2.3% |
| FY2021 | $2.45B | 9.2% | 6.4% |
How does AHCO compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 23 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: HCA · THC · UHS · LH · DVA · CYH
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.